E-cigarette Containing Methamphetamine: Illegal Drug Cases Uncovered in Chongqing

Regulations by 2FIRSTS.ai
Nov.23.2023
E-cigarette Containing Methamphetamine: Illegal Drug Cases Uncovered in Chongqing
The Chongqing police have successfully cracked down on two drug cases involving the sale of e-cigarettes containing etizolam since October.

According to China News Network, the police in Yuzhong district have successfully cracked two consecutive drug trafficking cases involving e-cigarettes containing the substance ethyl methylphenidate, from October until now. Cigarettes and e-cigarettes containing this substance are prohibited.

 

Starting from October 1st, using dichloromethane (MT) for non-medical purposes has been officially categorized as a type II controlled substance. Illegally trafficking or consuming dichloromethane is considered a criminal offense. Drug users typically abuse dichloromethane by adding it to the tobacco in cigarettes or inhaling it through e-liquids.

 

Earlier, the Yuzhong police received a public report about someone illegally selling e-cigarettes containing "etomidate" online. Police officers captured a suspect named Ye at the entrance of a residential area in Yuzhong District, who was allegedly involved in the illegal sale of etomidate. At the scene, four etomidate e-cigarette pods and two e-cigarette cartridges were seized. Currently, Ye has been placed under criminal detention in accordance with the law, and he also faces administrative punishment for using etomidate.

 

On October 11th, the police in Yuzhong district received another public report, alleging that someone was involved in illegal trading of N-ethylamphetamine within their jurisdiction. After meticulous investigation and analysis by the police, the suspects, Mr. Li and Ms. Li, were swiftly identified and successfully apprehended on the same day. Upon interrogation, both suspects confessed to the drug trafficking charges and are currently under criminal detention in accordance with the law.

 

Methoxyflurane is a white powdery substance that is insoluble in water. It is a non-barbiturate intravenous short-acting hypnotic drug, commonly used in medical practice in two formulations: a solution and an emulsion. Due to its minimal effects on the respiratory and circulatory systems, it is frequently used as one of the drugs for anesthesia induction. In clinical settings, it is primarily used for general anesthesia induction but can also be utilized for short-term surgical anesthesia.

 

People who consume methamphetamine experience symptoms such as dizziness, unsteady stance, slurred speech, and trembling hands. In severe cases, they may faint, lose consciousness, or even die. Long-term, high-dose methamphetamine use can lead to emotional disturbances, irritability, laziness, and affect an individual's mood, thoughts, and behavior.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

AIR Romania Manufacturing Facility Expected to Begin Operations in Q1 2027
AIR Romania Manufacturing Facility Expected to Begin Operations in Q1 2027
AIR Limited announced on May 7, 2026, that it plans to open a new manufacturing facility of approximately 70,000 square feet in Stefanesti, Bucharest North, Romania. The facility is expected to begin operations by the first quarter of 2027. AIR said that once fully operational, the facility is expected to support more than 150 jobs and be capable of producing more than 4,000 tons of flavored shisha molasses each year.
May.08 by 2FIRSTS.ai
From Brands to Supply Chains: 2Firsts Builds a PMTA Compliance Service System for the U.S. Market
From Brands to Supply Chains: 2Firsts Builds a PMTA Compliance Service System for the U.S. Market
2Firsts supports new tobacco and nicotine companies entering the U.S. market with full-chain PMTA compliance services.
Jun.04
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13
Altria and Juul Ask Court to Pause Antitrust Case Pending Ninth Circuit Review
Altria and Juul Ask Court to Pause Antitrust Case Pending Ninth Circuit Review
Altria and Juul are asking a California federal court to pause an antitrust case while they appeal a class certification ruling to the Ninth Circuit. The case alleges that Altria’s 2018 investment in Juul, a $12.8 billion deal for a 35% stake.
May.07 by 2FIRSTS.ai
State Registries Are Reshaping U.S. Vape Market Access 2Firsts Interview with U.S. Vapor Manufacturers Association President Allison Boughner
State Registries Are Reshaping U.S. Vape Market Access 2Firsts Interview with U.S. Vapor Manufacturers Association President Allison Boughner
As the U.S. vapor market faces FDA authorizations, import seizures and growing state-level restrictions, AVM President Allison Boughner told 2Firsts that state product registries and white-list systems are having the most immediate impact. She said distributors are placing greater weight on documentation, product origin and supply-chain transparency.
Special Report
May.26
Nicotine Pouches Lead U.S. Tobacco Growth as Vape Sales Decline
Nicotine Pouches Lead U.S. Tobacco Growth as Vape Sales Decline
New convenience store industry data show nicotine pouches have become the primary growth driver in the tobacco category, with oral nicotine sales rising nearly 30% over the past year while vape sales declined.
Business
Jun.05